341 related articles for article (PubMed ID: 25879391)
21. Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients in relation to quality of life.
Wyrzykowska N; Czarnecka-Operacz M; Adamski Z
Eur Ann Allergy Clin Immunol; 2015 Jan; 47(1):5-9. PubMed ID: 25599552
[TBL] [Abstract][Full Text] [Related]
22. Atopic dermatitis treatment: Current state of the art and emerging therapies.
Silverberg JI
Allergy Asthma Proc; 2017 Jul; 38(4):243-249. PubMed ID: 28668106
[TBL] [Abstract][Full Text] [Related]
23. The pathology and immunology of atopic dermatitis.
Rahman S; Collins M; Williams CM; Ma HL
Inflamm Allergy Drug Targets; 2011 Dec; 10(6):486-96. PubMed ID: 21864272
[TBL] [Abstract][Full Text] [Related]
24. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure.
Wang IJ; Wang JY
Clin Exp Allergy; 2015 Apr; 45(4):779-87. PubMed ID: 25600169
[TBL] [Abstract][Full Text] [Related]
25. The role of vitamin D in atopic dermatitis.
Dębińska A; Sikorska-Szaflik H; Urbanik M; Boznański A
Dermatitis; 2015; 26(4):155-61. PubMed ID: 26172483
[TBL] [Abstract][Full Text] [Related]
26. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children.
Weisshaar E; Diepgen TL; Bruckner T; Fartasch M; Kupfer J; Lob-Corzilius T; Ring J; Scheewe S; Scheidt R; Schmid-Ott G; Schnopp C; Staab D; Szcepanski R; Werfel T; Wittenmeier M; Wahn U; Gieler U
Acta Derm Venereol; 2008; 88(3):234-9. PubMed ID: 18480921
[TBL] [Abstract][Full Text] [Related]
27. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
Sunderkötter C; Weiss JM; Bextermöller R; Löffler H; Schneider D
J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
[TBL] [Abstract][Full Text] [Related]
28. Atopic dermatitis treatment: what's new on the horizon?
Panarese F; Auriemma M; Carbone A; Amerio P
G Ital Dermatol Venereol; 2018 Feb; 153(1):95-101. PubMed ID: 29319277
[TBL] [Abstract][Full Text] [Related]
29. Regulatory T cells in atopic dermatitis.
Oiso N
Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):244-8. PubMed ID: 19607647
[TBL] [Abstract][Full Text] [Related]
30. Dupilumab, A Monoclonal Antibody for Atopic Dermatitis: A Review of Current Literature.
Blakely K; Gooderham M; Papp K
Skin Therapy Lett; 2016 Mar; 21(2):1-5. PubMed ID: 27223113
[TBL] [Abstract][Full Text] [Related]
31. Effect of standard medication on quality of life of patients with atopic dermatitis.
Kawashima M; Harada S
J Dermatol; 2007 Jan; 34(1):9-16. PubMed ID: 17204095
[TBL] [Abstract][Full Text] [Related]
32. Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis.
Yano C; Saeki H; Ishiji T; Ishiuji Y; Sato J; Tofuku Y; Nakagawa H
J Dermatol; 2013 Sep; 40(9):736-9. PubMed ID: 23834561
[TBL] [Abstract][Full Text] [Related]
33. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life.
Coutanceau C; Stalder JF
Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258
[TBL] [Abstract][Full Text] [Related]
34. Atopic dermatitis: a new treatment paradigm using pimecrolimus.
Weinberg JM; Bowerman JG; Brown SM; Gerstein D; Kane KS; Selevan J; Virdee S
J Drugs Dermatol; 2003 Apr; 2(2):131-40. PubMed ID: 12852364
[TBL] [Abstract][Full Text] [Related]
35. Gene expression in canine atopic dermatitis and correlation with clinical severity scores.
Wood SH; Clements DN; Ollier WE; Nuttall T; McEwan NA; Carter SD
J Dermatol Sci; 2009 Jul; 55(1):27-33. PubMed ID: 19394200
[TBL] [Abstract][Full Text] [Related]
36. Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice.
Lebwohl M; Alexis AF; Beck LA; Block JK; Eichenfield LF; Fonacier L; Guttman-Yassky E; Paller AS; Pariser D; Silverberg JI; Boguniewicz M
J Drugs Dermatol; 2019 Feb; 18(2):122-129. PubMed ID: 30794360
[TBL] [Abstract][Full Text] [Related]
37. Omalizumab for the treatment of atopic dermatitis.
Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
[TBL] [Abstract][Full Text] [Related]
38. Is the skin barrier abnormal in dogs with atopic dermatitis?
Olivry T
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):11-6. PubMed ID: 21835476
[TBL] [Abstract][Full Text] [Related]
39. Future treatment options for atopic dermatitis - small molecules and beyond.
Schäkel K; Döbel T; Bosselmann I
J Dermatol Sci; 2014 Feb; 73(2):91-100. PubMed ID: 24360854
[TBL] [Abstract][Full Text] [Related]
40. miRNAs in inflammatory skin diseases and their clinical implications.
Løvendorf MB; Skov L
Expert Rev Clin Immunol; 2015 Apr; 11(4):467-77. PubMed ID: 25719822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
